BioWorld BioWorld MedTech BioWorld Asia

BioWorld

Just Adaurable: Astrazeneca’s phase III Tagrisso data captivate at ASCO
Astrazeneca plc’s Tagrisso (osimertinib) seems poised to become standard of care in the adjuvant setting for early stage (IB, II and IIIA) EGFR-mutated non-small-cell lung...

More in BioWorld

BioWorld MedTech

FDA clears the way for Letsgetchecked’s at-home COVID-19 test
New York-based at-home testing startup Letsgetchecked said Friday that the U.S. FDA has granted emergency use authorization (EUA) for its COVID-19 Sure-track Test for signs...

More in BioWorld MedTech

BioWorld Asia

Kintor’s $240M IPO well received in Hong Kong; CEO says internal early stage R&D will be future focus
BEIJING – Androgen receptor (AR)-related disease specialist Kintor Pharmaceutical Ltd., of Suzhou, China, raised $240 million on the Hong Kong Stock Exchange (HKEX) on May...

More in BioWorld Asia